AXGN — Axogen Inc

Axogen Inc (AXGN) is a medical devices company listed on NASDAQ. It is led by Michael D. Dale, based in 13631 Progress Boulevard, Alachua, FL, United States, 32615, with about 451 employees. Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. Axogen, Inc. is headquartered in Alachua, Florida.

Latest reported AXGN revenue for 2025-09-30 was $60.1M. Net income was $708.0K. Revenue was up 6.0% from 2025-06-30 to 2025-09-30. AXGN currently screens at market cap $497.8M.

Use this AXGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the AXGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the AXGN SEC filings page. Lician reads the product cache first so this HTML stays unique to Axogen Inc even when a live quote feed is slow.